Many cancer types divide rapidly and require large quantities of DNA precursors. Cells make them through two pathways: de novo synthesis and salvage. I use mass spectrometry to study the relationship between the two pathways and better understand vulnerabilities exploitable for therapy.
I completed my MChem degree in Chemistry at Oxford (2012-2016).
I am part of the ORCRB Social and Green committees.